iPRIME closes to recruitment, Assoc Prof Tarek Meniawy shares his insights on the study
iPRIME is an ovarian cancer clinical trial that tests how safe and effective the combination treatment of durvalumab and tremelimumab with standard chemotherapy can be as a treatment for newly diagnosed patients with ovarian, fallopian tube or [...]